Further to the cautionary statements published in the press on 05 September 2019 and 26 September 2019, shareholders are advised that the directors of MedTech Holdings Limited (“Medtech” or “company”) are in discussions to sell certain of the company’s operating assets and also for the acquisition of a business in a different sector.
The proposed transactions would constitute a “Category 1” transaction under Part X of the Securities and Exchange (Zimbabwe Stock Exchange Listings Requirements) Rules, 2019 (“listing rules”) and may also constitute a Reverse Takeover.
These transactions may have a material effect on the price of the company’s securities. Accordingly, shareholders are advised to exercise caution when dealing in the company’s securities until a full announcement is made.
BY ORDER OF THE BOARD
M Y Patel